NCT04538976View on ClinicalTrials.gov

Copd Exacerbation and Pulmonary Hypertension Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

February 1, 2020

Primary Completion Date

March 15, 2024

Study Completion Date

March 15, 2024

Conditions
Acute Exacerbation of COPD
Interventions
DRUG

Sildenafil

Sildenafil in standard dosage

Trial Locations (5)

Unknown

Bispebjerg University Hospital, Copenhagen

Herlev-Gentofte Hospital, Copenhagen

Hvidovre Hospital, Copenhagen

Nordsjællands Hospital, Hillerød

Odense Universitetshospital, Odense

All Listed Sponsors
lead

Chronic Obstructive Pulmonary Disease Trial Network, Denmark

OTHER

NCT04538976 - Copd Exacerbation and Pulmonary Hypertension Trial | Biotech Hunter | Biotech Hunter